February 24, 1987
Pancretec Inc. has reported increased second-quarter sales and an urgently needed $700,000 cash infusion from a local venture capital firm, Ventana Growth Fund. But losses continue at the medical supply company, which, despite the investment, still has a negative net worth. A manufacturer of ambulatory drug delivery systems, Pancretec reported a net loss of $161,528, or 9 cents per share, on revenue of $755,000 over the three months ended Dec. 31.
March 24, 1987 |
Six months ago, Pancretec Inc.'s days appeared numbered. The 4-year-old medical supply company was virtually out of cash, had just hired its third chief executive in seven months, and, after an unbroken string of quarterly losses totaling $5.5 million, seemed unable to turn a profit. Today, Pancretec may be on the road to recovery. Second-quarter sales were double those of the previous year and prospects for continued growth have improved, in part because of the spreading AIDS epidemic.
April 24, 1988 |
Tiny bubbles provided a big payoff for investors in Molecular Biosystems, the leader on The Times' list of top stock performers for San Diego County. Microscopic bubbles called "microspheres" are the basis of the company's new ultrasound imaging agent that may be the first to enable cardiologists to see real-time images of blood flowing through the heart.